相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways
Limor Avrahami et al.
CELLULAR SIGNALLING (2020)
CRMP2 mediates GSK3β actions in the striatum on regulating neuronal structure and mania-like behavior
Wonju Kim et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease
Kunhua Hu et al.
NEUROSCIENCE (2019)
Mechanistic comparison between MPTP and rotenone neurotoxicity in mice
Sunil Bhurtel et al.
NEUROTOXICOLOGY (2019)
Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
Gueliz Armagan et al.
MOLECULES (2019)
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3
Mahboubeh S. Noori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson's disease
Qing Yu et al.
EXPERIMENTAL NEUROLOGY (2018)
Medical and Surgical Management of Advanced Parkinson's Disease
Angelo Antonini et al.
MOVEMENT DISORDERS (2018)
AMO-02 (tideglusib) for the treatment of congenital and childhood onset myotonic dystrophy type 1
J. Horrigan et al.
NEUROMUSCULAR DISORDERS (2018)
Role of c-Abl-GSK3β Signaling in MPP+-Induced Autophagy-Lysosomal Dysfunction
Yixian Ren et al.
TOXICOLOGICAL SCIENCES (2018)
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Geraldine Gelders et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Przemyslaw Duda et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice
Yea-Hwey Wang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Parkinson's Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh et al.
FRONTIERS IN NEUROSCIENCE (2018)
A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TIDEGLUSIB, AN ORALLY ADMINISTERED GSK-3 BETA INHIBITOR, IN THE TREATMENT OF ADOLESCENTS WITH ASD
Evdokia Anagnostou et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2018)
GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib
Theodore Lemuel Mathuram et al.
DRUG RESEARCH (2018)
Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA- Induced Parkinson's Disease Mice
Lin Chen et al.
NEUROCHEMICAL RESEARCH (2017)
Kinase targets in CNS drug discovery
Hendra Gunosewoyo et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3β) and NF-κB/p65 signalling
Qiong Cao et al.
PLOS ONE (2017)
The Key Roles of GSK-3 beta in Regulating Mitochondrial Activity
Kai Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Effects of Early Life Lead Exposure on the Expression of Glycogen Synthase Kinase-3β and Insulin-like Growth Factor 1 Receptor in the Hippocampus of Mouse Pups
Ning Li et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2016)
JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease
Qiaoying Huang et al.
EXPERIMENTAL NEUROLOGY (2016)
Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity
Chin-Hsien Lin et al.
HUMAN MOLECULAR GENETICS (2016)
Protein kinase C controls lysosome biogenesis independently of mTORC1
Yang Li et al.
NATURE CELL BIOLOGY (2016)
Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells
Benoit Marchand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich et al.
PHARMACOLOGICAL RESEARCH (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β
Iwona A. Cymerman et al.
PLOS ONE (2015)
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
J. J. Credle et al.
CELL DEATH AND DIFFERENTIATION (2015)
Hippocampal GSK3 beta as a Molecular Link Between Obesity and Depression
Ioannis K. Papazoglou et al.
MOLECULAR NEUROBIOLOGY (2015)
Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth
I. Azoulay-Alfaguter et al.
ONCOGENE (2015)
A Phase II Trial of Tideglusib in Alzheimer's Disease
Simon Lovestone et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
BAX channel activity mediates lysosomal disruption linked to Parkinson disease
Jordi Bove et al.
AUTOPHAGY (2014)
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2014)
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
Guenter U. Hoeglinger et al.
MOVEMENT DISORDERS (2014)
GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation
Meghan Morgan-Smith et al.
ELIFE (2014)
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
J. A. Morales-Garcia et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
Limor Avrahami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Parkinson's Disease-Associated Dj-1 Mutations Increase Abnormal Phosphorylation of Tau Protein through Akt/Gsk-3β Pathways
Yangang Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Sheila M. Fleming et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Juan Manuel Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
David E. Hurtado et al.
JOURNAL OF NEUROSCIENCE (2012)
Glycogen Synthase Kinase-3β Is Involved in Ligand-Dependent Activation of Transcription and Cellular Localization of the Glucocorticoid Receptor
Camila Rubio-Patino et al.
MOLECULAR ENDOCRINOLOGY (2012)
Lysosomal membrane permeabilization in Parkinson disease
Miquel Vila et al.
AUTOPHAGY (2011)
Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanism
Juliet C. Russell et al.
CELLULAR SIGNALLING (2011)
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease
M. T. Armentero et al.
NEUROBIOLOGY OF AGING (2011)
GSK-3: functional insights from cell biology and animal models
Oksana Kaidanovich-Beilin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Eleonore Beurel
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
Inhibitory Phosphorylation of GSK-3 by CaMKII Couples Depolarization to Neuronal Survival
Bin Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy
Raquel Gomez-Sintes et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
Leslie Crews et al.
PLOS ONE (2010)
Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
Christopher J. Yuskaitis et al.
CELLULAR SIGNALLING (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3
Ulla Nuutinen et al.
LEUKEMIA RESEARCH (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
A COMPARISON OF MODEL-BASED (2D) AND DESIGN-BASED (3D) STEREOLOGICAL METHODS FOR ESTIMATING CELL NUMBER IN THE SUBSTANTIA NIGRA PARS COMPACTA (SNpc) OF THE C57BL/6J MOUSE
Z. C. Baquet et al.
NEUROSCIENCE (2009)
Glycogen synthase kinase-3beta is associated with Parkinson's disease
Masahiro Nagao et al.
NEUROSCIENCE LETTERS (2009)
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Oksana Kaidanovich-Beilin et al.
MOLECULAR BRAIN (2009)
Differential regulation of STAT family members by glycogen synthase kinase-3
Eleonore Beurel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: Roles of glycogen synthase kinase-3 inhibition
Yan Leng et al.
JOURNAL OF NEUROSCIENCE (2008)
The Wnt pool of glycogen synthase kinase 3β is critical for trophic-deprivation-induced neuronal death
Vesa Hongisto et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tissue-specific role of glycogen synthase kinase 3β in glucose homeostasis and insulin action
Satish Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism
Katrina MacAulay et al.
CELL METABOLISM (2007)
Astrocytic expressions of phosphorylated Akt, GSK3β and CREB following an excitotoxic lesion in the mouse hippocampus
Dong Woon Kim et al.
NEUROCHEMICAL RESEARCH (2007)
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
Min-Huei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Activation of the Akt/GSK3β signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats
Hidenori Endo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3
M Martin et al.
NATURE IMMUNOLOGY (2005)
Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: Protection by mood stabilizers and imipramine
MS Roh et al.
BIOLOGICAL PSYCHIATRY (2005)
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
GE Meredith et al.
BRAIN RESEARCH (2002)
分享论文
